文献速递呼吸道感染呼吸危重症与机械通气

重症流感ICU患者侵袭性肺曲霉病回顾性队列研究

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
PubMed 文献 · Lancet Respir Med · 2018-07-31

该回顾性多中心队列研究纳入比利时和荷兰7个ICU在7个流感季收治的成人重症流感患者,旨在评估侵袭性肺曲霉病的发生率及流感是否为独立危险因素。结果显示流感患者中侵袭性肺曲霉病发生率为19%,非免疫抑制流感患者为14%,而对照组仅5%;

要点

  • 重症流感患者侵袭性肺曲霉病发生率为19%,免疫抑制者达32%。
  • 合并侵袭性肺曲霉病者90天死亡率51%,显著高于无合并者28%。

核心结论

  • 流感被确定为侵袭性肺曲霉病的独立危险因素,并与高死亡率相关。

研究设计与样本

  • 回顾性多中心队列研究,收集2009年1月1日至2016年6月30日比利时和荷兰7个ICU的成人重症流感患者数据,覆盖7个流感季。
  • 纳入标准为年龄>18岁、因急性呼吸衰竭入住ICU>24小时、影像学有肺部浸润、气道PCR确诊流感。
  • 采用 logistic 回归分析比较非免疫抑制流感阳性患者(流感病例组)与非免疫抑制且气道流感PCR阴性的重症社区获得性肺炎患者(对照组)。

主要发现

  • 432例流感患者中83例(19%)诊断为侵袭性肺曲霉病,诊断中位时间为入住ICU后3天。
  • 流感A和B的侵袭性肺曲霉病发生率相似。
  • 免疫抑制流感患者侵袭性肺曲霉病发生率为32%(38/117),非免疫抑制流感病例组为14%(45/315)。
  • 对照组315例中仅16例(5%)发生侵袭性肺曲霉病。

关键数值与推荐

  • 其他相关因素包括较高的APACHE II评分、男性、使用糖皮质激素。
  • 免疫抑制定义采用EORTC/MSG宿主因素标准。

临床怎么用

  • 对ICU重症流感患者应警惕侵袭性肺曲霉病,尤其在免疫抑制、高APACHE II评分、男性及使用糖皮质激素者。
  • 流感相关侵袭性肺曲霉病死亡率高,需考虑早期诊断或抗真菌预防以改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Invasive pulmonary aspergillosis typically occurs in an immunocompromised host. For almost a century, influenza has been known to set up for bacterial superinfections, but recently patients with severe influenza were also reported to develop invasive pulmonary aspergillosis. We aimed to measure the incidence of invasive pulmonary aspergillosis over several seasons in patients with influenza pneumonia in the intensive care unit (ICU) and to assess whether influenza was an independent risk factor for invasive pulmonary aspergillosis. METHODS: We did a retrospective multicentre cohort study. Data were collected from adult patients with severe influenza admitted to seven ICUs across Belgium and The Netherlands during seven influenza seasons. Patients were older than 18 years, were admitted to the ICU for more than 24 h with acute respiratory failure, had pulmonary infiltrates on imaging, and a confirmed influenza infection based on a positive airway PCR test (influenza cohort). We used logistic regression analyses to determine if influenza was independently associated with invasive pulmonary aspergillosis in non-immunocompromised (ie, no European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group [EORTC/MSG] host factor) influenza-positive patients (influenza case group) compared with non-immunocompromised patients with severe community-acquired pneumonia who had a negative airway influenza PCR test (control group). FINDINGS: Data were collected from patients admitted to the ICU between Jan 1, 2009, and June 30, 2016. Invasive pulmonary aspergillosis was diagnosed in 83 (19%) of 432 patients admitted with influenza (influenza cohort), a median of 3 days after admission to the ICU. The incidence was similar for influenza A and B. For patients with influenza who were immunocompromised, incidence of invasive pulmonary aspergillosis was as high as 32% (38 of 117 patients), whereas in the non-immunocompromised influenza case group, incidence was 14% (45 of 315 patients). Conversely, only 16 (5%) of 315 patients in the control group developed invasive pulmonary aspergillosis. The 90-day mortality was 51% in patients in the influenza cohort with invasive pulmonary aspergillosis and 28% in the influenza cohort without invasive pulmonary aspergillosis (p=0·0001). In this study, influenza was found to be independently associated with invasive pulmonary aspergillosis (adjusted odds ratio 5·19; 95% CI 2·63-10·26; p<0·0001), along with a higher APACHE II score, male sex, and use of corticosteroids. INTERPRETATION: Influenza was identified as an independent risk factor for invasive pulmonary aspergillosis and is associated with high mortality. Future studies should assess whether a faster diagnosis or antifungal prophylaxis could improve the outcome of influenza-associated aspergillosis. FUNDING: None.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018. PMID: 30076119. doi:10.1016/S2213-2600(18)30274-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。